495 related articles for article (PubMed ID: 29790179)
1. Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients.
van Veenendaal LM; van Akkooi ACJ; Verhoef C; Grünhagen DJ; Klop WMC; Valk GD; Tesselaar MET
J Surg Oncol; 2018 Jun; 117(8):1768-1775. PubMed ID: 29790179
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.
Bhatia S; Storer BE; Iyer JG; Moshiri A; Parvathaneni U; Byrd D; Sober AJ; Sondak VK; Gershenwald JE; Nghiem P
J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27245173
[TBL] [Abstract][Full Text] [Related]
3. Merkel cell carcinoma: 30-year experience from a single institution.
Santamaria-Barria JA; Boland GM; Yeap BY; Nardi V; Dias-Santagata D; Cusack JC
Ann Surg Oncol; 2013 Apr; 20(4):1365-73. PubMed ID: 23208132
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
Smith VA; Camp ER; Lentsch EJ
Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients.
Howle JR; Hughes TM; Gebski V; Veness MJ
J Am Acad Dermatol; 2012 Jul; 67(1):33-40. PubMed ID: 21996296
[TBL] [Abstract][Full Text] [Related]
6. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution.
Fields RC; Busam KJ; Chou JF; Panageas KS; Pulitzer MP; Kraus DH; Brady MS; Coit DG
Ann Surg Oncol; 2011 Sep; 18(9):2529-37. PubMed ID: 21431988
[TBL] [Abstract][Full Text] [Related]
7. Merkel cell carcinoma: report of 10 cases and review of the literature.
Akhtar S; Oza KK; Wright J
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):755-67. PubMed ID: 11050578
[TBL] [Abstract][Full Text] [Related]
8. Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma.
Fields RC; Busam KJ; Chou JF; Panageas KS; Pulitzer MP; Allen PJ; Kraus DH; Brady MS; Coit DG
Cancer; 2012 Jul; 118(13):3311-20. PubMed ID: 22072529
[TBL] [Abstract][Full Text] [Related]
9. Predictors of survival and recurrence in the surgical treatment of merkel cell carcinoma of the extremities.
Senchenkov A; Barnes SA; Moran SL
J Surg Oncol; 2007 Mar; 95(3):229-34. PubMed ID: 17323336
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma: high recurrence rate despite aggressive treatment.
Soult MC; Feliberti EC; Silverberg ML; Perry RR
J Surg Res; 2012 Sep; 177(1):75-80. PubMed ID: 22537840
[TBL] [Abstract][Full Text] [Related]
11. Merkel cell carcinoma: a clinicopathological study of 11 cases.
Acebo E; Vidaurrazaga N; Varas C; Burgos-Bretones JJ; Díaz-Pérez JL
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):546-51. PubMed ID: 16164706
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma.
Jouary T; Kubica E; Dalle S; Pages C; Duval-Modeste AB; Guillot B; Mansard S; Saiag P; Aubin F; Bedane C; Dalac S; Dompmartin A; Granel-Brocard F; Lok C; Stoebner PE; Lacour JP; Leccia MT; Diallo A; Ezzedine K; Mateus C
Acta Derm Venereol; 2015 Sep; 95(7):835-40. PubMed ID: 25784178
[TBL] [Abstract][Full Text] [Related]
13. Merkel cell carcinoma of the eyelid: management and prognosis.
Herbert HM; Sun MT; Selva D; Fernando B; Saleh GM; Beaconsfield M; Collin R; Uddin J; Meligonis G; Leatherbarrow B; Ataullah S; Irion L; McLean CJ; Huilgol SC; Davis G; Sullivan TJ
JAMA Ophthalmol; 2014 Feb; 132(2):197-204. PubMed ID: 24287584
[TBL] [Abstract][Full Text] [Related]
14. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.
Asgari MM; Sokil MM; Warton EM; Iyer J; Paulson KG; Nghiem P
JAMA Dermatol; 2014 Jul; 150(7):716-23. PubMed ID: 24807619
[TBL] [Abstract][Full Text] [Related]
15. Natural history of merkel cell carcinoma following locoregional recurrence.
Grotz TE; Tarantola TI; Otley CC; Weaver AL; McGree ME; Jakub JW
Ann Surg Oncol; 2012 Aug; 19(8):2556-62. PubMed ID: 22453243
[TBL] [Abstract][Full Text] [Related]
16. Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma.
Iyer JG; Storer BE; Paulson KG; Lemos B; Phillips JL; Bichakjian CK; Zeitouni N; Gershenwald JE; Sondak V; Otley CC; Yu SS; Johnson TM; Liegeois NJ; Byrd D; Sober A; Nghiem P
J Am Acad Dermatol; 2014 Apr; 70(4):637-643. PubMed ID: 24521828
[TBL] [Abstract][Full Text] [Related]
17. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease.
Foote M; Veness M; Zarate D; Poulsen M
J Am Acad Dermatol; 2012 Sep; 67(3):395-9. PubMed ID: 22030017
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patients.
Sims JR; Grotz TE; Pockaj BA; Joseph RW; Foote RL; Otley CC; Weaver AL; Jakub JW; Price DL
Surg Oncol; 2018 Mar; 27(1):11-17. PubMed ID: 29549898
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature.
Gupta SG; Wang LC; Peñas PF; Gellenthin M; Lee SJ; Nghiem P
Arch Dermatol; 2006 Jun; 142(6):685-90. PubMed ID: 16785370
[TBL] [Abstract][Full Text] [Related]
20. Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).
Suárez AL; Louis P; Kitts J; Busam K; Myskowski PL; Wong RJ; Chen CS; Spencer P; Lacouture M; Pulitzer MP
J Am Acad Dermatol; 2015 Dec; 73(6):968-75. PubMed ID: 26433246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
